# Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis

> **NCT06056973** · PHASE4 · UNKNOWN · sponsor: **The First Affiliated Hospital of Dalian Medical University** · enrollment: 260 (estimated)

## Conditions studied

- Reflux Esophagitis

## Interventions

- **DRUG:** jinghua weikang capsule

## Key facts

- **NCT ID:** NCT06056973
- **Lead sponsor:** The First Affiliated Hospital of Dalian Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06056973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06056973, "Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06056973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*